International Society of Ocular Oncology Biennial Conference
I

Eighteen Month Results of A Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Treatment of Small to Medium Choroidal Melanoma

By International Society of Ocular Oncology Biennial Conference FEATURING Ivana K. Kim
By International Society of Ocular Oncology Biennial Conference FEATURING Ivana K. Kim
4 views
September 30, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:07
Nebraska Oncology Society

NOS ASCO® 2023 Review: Nasopharynx Cancer

Feat. E. Sherman
13:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL…

Feat. P. Bossi
12:02
Insights from 2023 IFHNOS Annual Meeting

IFHNOS 2023 Insights: "Personalized (Precision) Medicine in Hea…

Feat. C. Stratakis
26:51
Paolo Bossi

Year in Review: Head & Neck Cancers

14:56
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key H&N Cancer Updates"

Feat. P. Bossi
23:38
2023 West Oncology Conference

Improving the Quality of Life for Head & Neck Cancer Survivors: …

Feat. B. Murphy
06:11
ecancer

ASCO® 2023 Insights: "Key Head & Neck Data"

Feat. G. Hanna
54:42
UNC Lineberger Comprehensive Cancer Center

2023 UNC Head and Neck Cancer Management Updates

Feat. J. Weiss, S. Sheth, W. Yarbrough, C. Shen
04:33
GRACE

Treatment Options for Patients With Head & Neck Cancer and High …

Feat. J. Weiss
04:46
GRACE

Emerging Treatment Options for Head and Neck Cancer

Feat. J. Weiss
02:49
GRACE

Major Advances in Uveal Melanoma

Feat. M. Postow
19:57
Michael Gibson

AHNS 2023 Insights: "HNSCC Updates - Tumor Microenvironment, Ne…

06:27
Insights from 2023 ASCO® Annual Meeting

Enfortumab Vedotin in the Previously Treated Advanced Head & Nec…

Feat. P. Swiecicki
10:16
ESMO 2022 Conference Coverage

ESMO 2022 H&N Updates

Feat. N. Saba
22:27
Nebraska Oncology Society

NOS ASCO® 2023 Review: Head & Neck Cancer De-Escalation

Feat. E. Sherman
08:09
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "AIM-HN Study Evaluating Tipifarnib in mHRA…

Feat. A. Ho
03:48
GRACE

Treatment of Recurrent/Metastatic HPV+ SCCHN

Feat. J. Weiss
08:36
i3 Health

Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence…

Feat. A. Sacco
02:34
Dana-Farber Cancer Institute

ESMO 2023 Insights: "AIM-HN Study - Evaluating Tipifarnib in mH…

Feat. R. Haddad
12:13
AACR 2023 Conference Coverage

Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Ant…

Feat. E. Cohen